Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways

Ahmed G. Abd Elhameed, Eman H. Yousef, Muhammed M. Salahuddin, Mostafa M. Bahaa, Amal Abdullah Alrashidi, Mohamad A. El‐Gammal

Open source

DOI: 10.1007/s00210-026-05726-7
Published: 2026-07-29
Container: Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05726-7,
  title = {Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways},
  author = {Ahmed G. Abd Elhameed and Eman H. Yousef and Muhammed M. Salahuddin and Mostafa M. Bahaa and Amal Abdullah Alrashidi and Mohamad A. El‐Gammal},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-05726-7},
  url = {https://doi.org/10.1007/s00210-026-05726-7}
}

RIS

TY  - JOUR
TI  - Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways
AU  - Ahmed G. Abd Elhameed
AU  - Eman H. Yousef
AU  - Muhammed M. Salahuddin
AU  - Mostafa M. Bahaa
AU  - Amal Abdullah Alrashidi
AU  - Mohamad A. El‐Gammal
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-05726-7
UR  - https://doi.org/10.1007/s00210-026-05726-7
ER  -

APA

Elhameed, A. G. A., Yousef, E. H., Salahuddin, M. M., Bahaa, M. M., Alrashidi, A. A., & El‐Gammal, M. A. (2026). Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05726-7

Source records

crossref · retrieved 2026-11-10T11:44:18.661Z